Safety Findings in Pediatric Patients During Long‐Term Treatment With Teduglutide for Short‐Bowel Syndrome–Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies

BACKGROUND: This analysis assessed combined safety data from 4 clinical studies of teduglutide in pediatric patients with short‐bowel syndrome–associated intestinal failure (SBS–IF). METHODS: Safety data from teduglutide‐treated patients in 4 clinical trials were pooled. The completed 12‐week and 24...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Susan, Carter, Beth A., Cohran, Valeria, Horslen, Simon, Kaufman, Stuart S., Kocoshis, Samuel A., Mercer, David F., Merritt, Russell J., Pakarinen, Mikko P., Protheroe, Susan, Thompson, John F., Vanderpool, Charles P. B., Venick, Robert S., Wales, Paul W., Smith, Sharon E., Yoon, MinJung, Grimm, Andrew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647158/
https://www.ncbi.nlm.nih.gov/pubmed/33305440
http://dx.doi.org/10.1002/jpen.2061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647158/
https://www.ncbi.nlm.nih.gov/pubmed/33305440
http://dx.doi.org/10.1002/jpen.2061

Ejemplares similares